Pharmaceutical Biotechnology, Center for System-Based Drug Research, and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, D-81377 Munich, Germany.
Pharmaceutical Biotechnology, Center for System-Based Drug Research, and Center for NanoScience (CeNS), Ludwig-Maximilians-Universität München, Butenandtstrasse 5-13, D-81377 Munich, Germany
Biosci Rep. 2017 Oct 31;37(5). doi: 10.1042/BSR20160617.
Nucleic acid molecules are important therapeutic agents in the field of antisense oligonucleotide, RNA interference, and gene therapies. Since nucleic acids are not able to cross cell membranes and enter efficiently into cells on their own, the development of efficient, safe, and precise delivery systems is the crucial challenge for development of nucleic acid therapeutics. For the delivery of nucleic acids to their intracellular site of action, either the cytosol or the nucleus, several extracellular and intracellular barriers have to be overcome. Multifunctional carriers may handle the different special requirements of each barrier. The complexity of such macromolecules however poses a new hurdle in medical translation, which is the chemical production in reproducible and well-defined form. Solid-phase assisted synthesis (SPS) presents a solution for this challenge. The current review provides an overview on the design and SPS of precise sequence-defined synthetic carriers for nucleic acid cargos.
核酸分子是反义寡核苷酸、RNA 干扰和基因治疗领域的重要治疗剂。由于核酸本身不能穿过细胞膜并有效地进入细胞,因此开发高效、安全和精确的递药系统是核酸治疗发展的关键挑战。为了将核酸递送到其细胞内作用部位,无论是细胞质还是细胞核,都需要克服几种细胞外和细胞内的屏障。多功能载体可以处理每个屏障的不同特殊要求。然而,这些大分子的复杂性在医学翻译中构成了一个新的障碍,即化学生产以可重复和明确的形式进行。固相辅助合成 (SPS) 为这一挑战提供了一个解决方案。本综述概述了核酸载物的精确序列定义合成载体的设计和 SPS。